Patents
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
08/2005
08/18/2005WO2005075426A1 Novel dipeptidyl peptidase iv inhibitors; processes for their preparation and compositions thereof
08/18/2005WO2005074654A2 Methods to manufacture 1,3-dioxolane nucleosides
08/18/2005US20050182073 Controlling microorganisms; e.g. agricultural fungicides; preservatives for e.g. lubricants, paints; chemical intermediates and synthesis thereof
08/18/2005US20050182072 Paget's disease; muscular disorders; cardiovascular disorders; antiinflamamtory agents; antidiabetic agents; autoimmune disease; leukemia
08/18/2005US20050182068 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
08/18/2005US20050182047 Treatment of demyelinating disorders
08/18/2005US20050182045 Fused ring 4-oxopyrimidine derivative
08/18/2005US20050182043 4-amino-6-cycloalkyloxy-7-substituted quinazolines; inhibition of signal transduction mediated by tyrosine kinases; antitumor agents, respiratory system and gastrointestinal disorders
08/18/2005CA2554782A1 Methods to manufacture 1,3-dioxolane nucleosides
08/18/2005CA2554705A1 Alpha-4 integrin mediated cell adhesion inhibitors for the treatment or prevention of inflammatory diseases
08/17/2005EP1562913A1 Substituted quinazolines as antiviral agents, especially against cytomegaloviruses
08/17/2005EP1562912A2 Process for preparation of rosuvastatin calcium
08/17/2005EP1562911A1 Compositions useful as inhibitors of jak and other protein kinases
08/17/2005EP1562902A1 2-pyridone derivatives as inhibitors of neutrophile elastase
08/17/2005EP1562895A1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
08/17/2005EP1562574A1 2-oxo-ethanesulfonamide derivates
08/17/2005EP1466174A4 Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571
08/17/2005EP0989982B1 Barbituric acid derivatives with antimetastatic and antitumor activity
08/17/2005CN1656109A Non nucleoside reverse transcriptase inhibitors
08/17/2005CN1656090A Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins
08/17/2005CN1656081A 4-anilino quinazoline derivatives as antiproliferative agents
08/17/2005CN1656080A Pyrimidone derivatives useful for the treatment of inflammation and immunological diseases
08/17/2005CN1656077A Process for preparing chiral diol sulfones and dihydroxy acid HMG CoA reductase inhibitors
08/17/2005CN1656073A Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
08/17/2005CN1654459A Substituted aminosalicylic acid amides with fungicidal effect and intermediate products for production thereof
08/17/2005CN1215061C Process for preparing anticancer compound, and intermediate
08/17/2005CN1215054C Microbicidal N-sulfonylglycin alkynyloxyphenemethyl amide derivatives
08/16/2005US6930112 Administering antagonist for n-methylaspartic acid or gamma-aminobutyric acid
08/16/2005US6930106 Inhibitors of HCV NS5B polymerase
08/16/2005US6930101 Thiazolopyrimidines useful as TNFα inhibitors
08/16/2005CA2238521C Diaminopyrimidines, pharmaceutical compositions containing them and their use as antibacterial
08/11/2005WO2005073165A1 Amide derivatives, process for production of the same, and method for application thereof as insecticide
08/11/2005WO2005051302A3 Bicyclic inhibitors of mek and methods of use thereof
08/11/2005WO2005020897A3 Compositions and methods for the treatment of disease associated with trp-p8 expression
08/11/2005WO2004014847A8 Mcp-1 receptor antagonists and method of use thereof
08/11/2005US20050176966 Process for the preparation of pyrimidine derivative, intermediate therefor and process for the preparation thereof
08/11/2005US20050176957 reacting nicotinic acid derivatives with amidine derivatives to yield substituted pyridopyrimidones
08/11/2005US20050176743 Sulfoximine-substituted pyrimidines as CDK-and/or VEGF inhibitors, their production and use as pharmaceutical agents
08/11/2005US20050176741 Quinazoline derivative and medicine
08/11/2005US20050176727 Male erectile dysfunction; 1-(3-chlorophenyl)-3-(4-pyridin-2-yl-piperazin-1-yl)propan-1-one O-methyloxime
08/11/2005US20050176721 2,5-Diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylprimidines
08/11/2005US20050176713 Amide derivatives as glycogen synthase kinase 3-beta inhibitors
08/11/2005US20050176707 Compositions and methods for inducing cell dedifferentiation
08/11/2005US20050176706 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
08/11/2005US20050176698 Neuropeptide Y antagonists
08/11/2005US20050172420 Based on diaminobenzanilides or, more specifically (aminobenzoylamino),(sulfo-),(methoxy)anilines; stable aqueous solutions;nonbleeding/colorfastness; excellent degrees of exhaustion with high colour strength; dyeing natural or synthetic materials, particularly, paper; neutral or greenish-yellow hues
08/11/2005DE102004003493A1 5-Phenylpyrimidine 5-phenylpyrimidines
08/11/2005DE102004002055A1 Verfahren zur Herstellung von 2-Amino-4,6-dichlor-5-formamidopyrimidin A process for the preparation of 2-amino-4,6-dichloro-5-formamidopyrimidine
08/10/2005EP1561741A1 Method for deuteration or tritiation of heterocyclic ring
08/10/2005EP1560878A1 Thermally stabilised pvc compositions
08/10/2005EP1560824A1 Compounds useful as inhibitors of jak and other protein kinases
08/10/2005EP1560816A1 Quinazoline derivatives
08/10/2005EP1560815A1 Novel pyrimidine-4,6-dicarboxamides for the selective inhibition of collagenases
08/10/2005EP1157002B1 1,2,3,4-tetrahydro-1-naphthalenamine compounds useful in therapy
08/10/2005CN1653073A Substituted phenylacetic acids
08/10/2005CN1653043A Method for the production of sulphamic acid halogenides
08/10/2005CN1653037A Substituted tetracycline compounds
08/10/2005CN1652790A Novel crystalline forms of the anti-cancer compound ZD1839
08/10/2005CN1652789A Heteroaryl compounds which inhibit leukocyte adhesion mediated by alpha-4 integrins
08/10/2005CN1652779A Treatment of chemokine mediated diseases
08/10/2005CN1651428A Preparation method of hydrobromic acid antifebrile dichroanone
08/10/2005CN1214014C HIV inhibiting pyrimidine derivatives
08/10/2005CN1214013C HIV replication inhibiting pyrimidines
08/10/2005CN1214011C Meta-azacyclic amino benzoic acid compound and derivatives thereof being integrin antagonists
08/10/2005CN1213989C New polymerisable liquid crystalline compounds
08/09/2005US6927225 Fungicidal 2-pyridyl alkyl amides and their compositions, methods of use and preparation
08/09/2005US6927193 And aryl sulfide derivatives
08/09/2005CA2199786C Process for the preparation of arylamides of heteroaromatic carboxylic acids
08/09/2005CA2188164C Benzamide compounds and pharmaceutical use thereof
08/04/2005WO2005070934A1 Substituted diazabicycloheptanes and their use as protein kinase inhibitors
08/04/2005WO2005070910A2 Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme
08/04/2005WO2005070909A1 An improved process for the preparation of gefitinib
08/04/2005WO2005070902A1 Therapeutic agents ii
08/04/2005WO2005070901A2 Pyrimidyl phosphonate antiviral compounds and methods of use
08/04/2005WO2005070900A1 N-4-(6- (heteo) aryl-pyrimidin-4-ylaminophenyl) -bezenesulfonamides as kinase inhibitors
08/04/2005WO2005070899A1 5-phenylpyrimidines and their use as microbicides
08/04/2005WO2005070891A2 Compounds and methods of use
08/04/2005WO2005070877A1 Diamino alcohols and their use as renin inhibitors
08/04/2005WO2004008837A9 Novel benzohydrazide derivatives as herbicides and desiccant compositions contaning them
08/04/2005US20050171366 Forming a diastereoselective epoxide from a chiral alpha-amino aldehyde; efficient synthesis of intermediates which are readily amenable to the large scale preparation of hydroxyethylurea-based chiral HIV protease inhibitors
08/04/2005US20050171355 important intermediate; without using an expensive catalyst and a special facilities; reacting a pyrimidinium derivative such as 1,3-dimethyl-2,3-dihydro-2-oxopyrimidinium chloride, an acetyl compound such as 4-acetylpyridine and an ammonia or an ammonium salt
08/04/2005US20050171347 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
08/04/2005US20050171181 Histamine-3 receptor modulators
08/04/2005US20050171163 MCP-1 receptor antagonists and methods of use thereof
08/04/2005US20050171136 Modulators of the glucocorticoid receptor and method
08/04/2005US20050171134 such as 4-[4-(1-Amino-1-methylethyl)phenyl]-5-chloro-N-[4-(2-hydroxyethyl)phenyl]pyrimidine-2-amine used as tyrosine kinase inhibitors, for prophylaxis disease states associated with angiogenesis
08/04/2005US20050171132 Diaminopyrimidine derivatives as selective growth hormone secrectgogue receptor (GHS-R) antagonists
08/04/2005US20050171131 Diaminopyrimidine derivatives as growth hormone secrectgogue receptor (GHS-R) antagonists
08/04/2005US20050171130 Pyrimidine compounds and their use as pesticides
08/04/2005US20050171123 Quinazoline derivatives as medicaments
08/04/2005US20050171109 Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
08/04/2005US20050171105 Methods and compositions as protein kinase inhibitors
08/04/2005US20050171103 Benzamide derivatives useful as histone deacetylase inhibitors
08/04/2005CA2553831A1 Diamino alcohols and their use as renin inhibitors
08/04/2005CA2553513A1 N-4-(6- (heteo) aryl-pyrimidin-4-ylaminophenyl) -bezenesulfonamides as kinase inhibitors
08/04/2005CA2553232A1 Substituted heterocyclic compounds and methods of use
08/04/2005CA2552584A1 Pyrimidyl phosphonate antiviral compounds and methods of use
08/03/2005EP1559711A1 Preparation of pyridine derivatives using pyrimidinium derivatives as intermediates
08/03/2005EP1558615A1 Purine compounds and use thereof as cannabinoid receptor ligands
08/03/2005EP1558585A1 Neurologically-active compounds